Compare ACRS & MLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACRS | MLR |
|---|---|---|
| Founded | 2012 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.9M | 617.4M |
| IPO Year | 2015 | 2004 |
| Metric | ACRS | MLR |
|---|---|---|
| Price | $3.33 | $51.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | $10.18 | ★ $58.00 |
| AVG Volume (30 Days) | ★ 3.5M | 60.4K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.64% |
| EPS Growth | ★ 69.01 | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | $1,683,000.00 | ★ $790,271,000.00 |
| Revenue This Year | N/A | $15.95 |
| Revenue Next Year | N/A | $11.38 |
| P/E Ratio | ★ N/A | $75.40 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.93 | $35.72 |
| 52 Week High | $6.60 | $59.70 |
| Indicator | ACRS | MLR |
|---|---|---|
| Relative Strength Index (RSI) | 28.14 | 33.15 |
| Support Level | $3.16 | $45.95 |
| Resistance Level | $3.44 | $52.80 |
| Average True Range (ATR) | 0.33 | 1.44 |
| MACD | -0.08 | -0.24 |
| Stochastic Oscillator | 6.31 | 0.52 |
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.
Miller Industries Inc is a manufacturer of Towing and Recovery Equipment. The company designs and manufactures bodies of car carriers and wreckers, which are installed on chassis manufactured by third parties, and sold to customers. Its product lines include car carriers, light duty, heavy duty, rotators, special transport, military, wreckers, and transport trailers. It sells products under various brands including Century, Vulcan, Chevron, Holmes, Challenger, Champion, Jige, Boniface, Omars, Titan, and Eagle.